Previous studies have found that caffeine is the world's most popular stimulant and psychoactive substance, and coffee is the most common way people consume caffeine.

20 Jul 2026

Smarter hospital design could save $100 million in the long-term

A modeling study reveals that smarter hospital design can generate $100 million in long-term savings while fostering healthier healthcare environments.

20 Jul 2026

Chrononutrition shows promise for postpartum weight management

New research has found that eating habits that align most closely with a woman's existing routine show promise for losing postpartum baby weight, especially for mothers earlier in the postpartum period.

20 Jul 2026

Global childhood IBD trends reveal unequal progress in diagnosis and survival

An analysis of GBD 2021 estimates across 204 countries and territories found that global deaths from early-onset IBD fell by approximately 71% among children younger than 10 between 1990 and 2021. However, estimated incident and prevalent case numbers rose while the age-standardized incidence rate remained broadly stable, with persistent socioeconomic and regional inequalities.

20 Jul 2026

Popular diabetes drugs do not alter the risk of developing a blinding eye condition

An estimated 27% of U.S. adults with diabetes are using glucagon-like peptide-1 receptor agonists (GLP-1 RAs) - a type of medication that mimics the GLP-1 hormone - to lower blood sugar and support weight loss. Some research has suggested that their use can reduce the risk of developing other diseases.

17 Jul 2026

New battery-powered device detects Bundibugyo Ebola virus in thirty minutes

Professor Yasutoshi Kido of the Graduate School of Medicine, Osaka Metropolitan University (OMU), in collaboration with K.K. DNAFORM and the National Institute for Biomedical Research (INRB) of the Democratic Republic of the Congo, is developing a portable rapid diagnostic system for Ebola virus disease (EVD) caused by Bundibugyo virus (BDBV).

17 Jul 2026

Compounded GLP-1 drug market remains strong despite shortage ending

Despite the end of federal shortages of popular GLP-1 weight-loss medications, the market for compounded alternatives remains strong – and some patients may unknowingly be receiving products from pharmacies with concerning regulatory histories, according to new research from the University of Colorado Anschutz.

17 Jul 2026

G&H highlights end-to-end diagnostic device development at ADLM 2026

At the ADLM Clinical Lab Expo 2026, G&H will showcase how diagnostic and medical device companies can accelerate the development and commercialization of innovative healthcare technologies through a single partner offering multidisciplinary engineering, precision optics, photonics and ISO 13485-certified manufacturing.

17 Jul 2026

Study urges Japan to rethink universal healthcare by 2040

On July 16, 2026, an international research team led by Tohoku University published two policy review papers that examine Japan's health system and global health strategy in The Lancet Regional Health - Western Pacific - the Lancet group's first Japan-focused feature in about 15 years.

17 Jul 2026

A breakthrough in coronary bypass surgery: AMT Medical’s SAFE-CAB results published in The Journal of Thoracic and Cardiovascular Surgery

AMT Medical B.V., a clinical-stage Dutch medical technology company, today announced that the one-year results of the SAFE-CAB II clinical trial have been published in The Journal of Thoracic and Cardiovascular Surgery.

17 Jul 2026

Leica Biosystems to acquire StatLab

...

17 Jul 2026

A wife’s account reveals the hidden burden of young-onset Alzheimer’s caregiving

Karina Acton Reid recounts caring for her husband with young-onset Alzheimer’s disease presenting as posterior cortical atrophy while raising two young children. Her perspective shows how visual disorientation, diagnostic delays, changing family roles, and inadequate age-appropriate support affect the entire household.

16 Jul 2026

New guideline offers recommendations for testosterone replacement therapy use

The Society's Clinical Practice Guideline on testosterone replacement therapy in men with hypogonadism offers recommendations on appropriate testing and prescribing practices.

16 Jul 2026

Long-term lenalidomide maintenance shows no survival advantage in multiple myeloma

For patients with newly diagnosed multiple myeloma not undergoing an autologous stem cell transplant, indefinite lenalidomide maintenance has long been standard care despite limited evidence to guide the optimal duration of treatment.

16 Jul 2026

Study highlights communication gaps between cancer survivors and providers on cannabis

For many cancer survivors, cannabis has become part of how they manage symptoms such as pain, nausea and anxiety.

16 Jul 2026

Fractional COVID booster doses provide strong long-lasting immunity

Smaller doses of COVID-19 booster vaccines can provide long-lasting immunity, helping to reduce costs and improve access to vaccination, according to new research. And the findings could also inform vaccine dosing and options during future pandemics.

16 Jul 2026

PET imaging reveals widespread brain receptor deficits in schizophrenia

A groundbreaking study using positron emission tomography (PET) imaging has found that patients with schizophrenia had significantly lower muscarinic acetylcholine M1 receptor availability (~13% to 19%) across multiple brain regions compared with healthy individuals.

16 Jul 2026

Post-Brexit drop in EU nurses linked to increased patient deaths

The sharp fall in EU nurses joining the NHS after the Brexit referendum may have contributed to more than 1,200 additional patient deaths each year in England, according to new research led by the University of Surrey in partnership with the University of Aberdeen, Harvard Business School and Vienna University of Economics and Business (WU).

16 Jul 2026